Ascletis 歌禮生物
歌禮生物科技(杭州)有限公司是一家新興的生物技術公司,致力于癌癥和傳染性疾病重要新療法的發現、開發和 商業化。歌禮專注于為發展中的中國制藥市場進行創新藥物的臨床開發和生產。歌禮由富有創業精神的管理層和資 深的科研團隊組成,具有為美國和歐洲的大型跨國制藥和新興生物技術公司成功發現并開發藥物的經驗。
Ascletis is an emerging biotechnology company, dedicated to discovering, developing and commercializing important new treatments for cancer and infectious diseases. Ascletis is focused on clinical development of innovative medicines and commercialization for the growing Chinese pharmaceutical marketplace. Ascletis has assembled an entrepreneurial management and senior scientific team with a track record of successful pharmaceutical discovery and development at major global pharmaceutical and emerging biotechnology companies in the United States and Europe.